FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Li, Chang Xian ^a   Shao, Yan ^a   Ng, Kevin T P ^a   Liu, Xiao Bing ^a   Ling, Chang Chun ^a   Ma, Yuen Yuen ^a   Geng, Wei ^a   Fan, Sheung Tat ^a   Lo, Chung Mau ^a   Man, Kwan ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; FINGOLIMOD; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; XCL10 CHEMOKINE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD SAMPLING; CELL COUNT; CIRCULATING TUMOR CELL; CONTROLLED STUDY; CXCL10 GENE; CXCR3 GENE; CXCR4 GENE; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; GENE EXPRESSION REGULATION; LIVER ISCHEMIA; LIVER METASTASIS; LIVER SURGERY; LIVER TUMOR; LUNG METASTASIS; METASTASIS INHIBITION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TUMOR GENE; VEGF GENE; ANIMAL; CANCER TRANSPLANTATION; CYTOLOGY; DRUG EFFECT; HUMAN; LIVER; LIVER CELL CARCINOMA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; STEM CELL; TIME; TUMOR CELL LINE;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROPYLENE GLYCOLS; RATS; REPERFUSION INJURY; SPHINGOSINE; STEM CELLS; TIME FACTORS;

EID: 84863291987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032380     Document Type: Article

References (39)

1. Bosch FX, Ribes J, Diaz M, Cleries R, (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16.
2. Doi K, Horiuchi T, Uchinami M, Tabo T, Kimura N, et al. (2002) Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res 105: 243-247.
3. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, et al. (2005) Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 42: 165-175.
4. Man K, Ng KT, Lo CM, Ho JW, Sun BS, et al. (2007) Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways. Liver Transpl 13: 1669-1677.
5. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438.
6. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, et al. (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103: 2776-2779.
7. Lemoli RM, Catani L, Talarico S, Loggi E, Gramenzi A, et al. (2006) Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells 24: 2817-2825.
8. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, et al. (2000) Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202.
9. Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, et al. (2005) G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 33: 108-119.
10. Natori T, Sata M, Washida M, Hirata Y, Nagai R, et al. (2002) G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun 297: 1058-1061.
11. Rookmaaker MB, Tolboom H, Goldschmeding R, Zwaginga JJ, Rabelink TJ, et al. (2002) Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood 99: 1095.
12. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, et al. (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017-3024.
13. Yu D, Sun X, Qiu Y, Zhou J, Wu Y, et al. (2007) Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 13: 3814-3824.
14. Ho JW, Pang RW, Lau C, Sun CK, Yu WC, et al. (2006) Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 44: 836-843.
15. Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, et al. (2003) Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4: 277-289.
16. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, et al. (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11: 261-262.
17. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201.
18. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, et al. (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198.
19. Kiuchi M, Adachi K, Kohara T, Minoguchi M, Hanano T, et al. (2000) Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J Med Chem 43: 2946-2961.
20. Zhao Y, Man K, Lo CM, Ng KT, Li XL, et al. (2004) Attenuation of small-for-size liver graft injury by FTY720: significance of cell-survival Akt signaling pathway. Am J Transplant 4: 1399-1407.
21. Man K, Ng KT, Lee TK, Lo CM, Sun CK, et al. (2005) FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. Am J Transplant 5: 40-49.
22. Lee TK, Man K, Ho JW, Wang XH, Poon RT, et al. (2005) FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res 11: 8458-8466.
23. Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, et al. (2002) Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 62: 1410-1419.
24. Azuma H, Takahara S, Horie S, Muto S, Otsuki Y, et al. (2003) Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J Urol 169: 2372-2377.
25. Zhou C, Ling MT, Kin-Wah Lee T, Man K, Wang X, et al. (2006) FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase. Cancer Lett 233: 36-47.
26. Ng KT, Man K, Ho JW, Sun CK, Lee TK, et al. (2007) Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway. Int J Oncol 30: 375-380.
27. Man K, Ng KT, Xu A, Cheng Q, Lo CM, et al. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res 16: 967-977.
28. Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, et al. (2002) Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20: 1775-1785.
29. Man K, Lo CM, Xiao JW, Ng KT, Sun BS, et al. (2008) The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 247: 1049-1057.
30. Man K, Shih KC, Ng KT, Xiao JW, Guo DY, et al. Molecular signature linked to acute phase injury and tumor invasiveness in small-for-size liver grafts. Ann Surg 251: 1154-1161.
31. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, et al. (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346.
32. De Palma M, Venneri MA, Naldini L, (2003) In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. Hum Gene Ther 14: 1193-1206.
33. Nozawa H, Chiu C, Hanahan D, (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A 103: 12493-12498.
34. Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, et al. (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol 25: 911-920.
35. Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, et al. (1998) The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91: 4523-4530.
36. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328.
37. Tian F, Liang PH, Li LY, (2009) Inhibition of endothelial progenitor cell differentiation by VEGI. Blood 113: 5352-5360.
38. Sato E, Fujimoto J, Toyoki H, Sakaguchi H, Alam SM, et al. (2007) Expression of IP-10 related to angiogenesis in uterine cervical cancers. Br J Cancer 96: 1735-1739.
39. Hicklin DJ, Ellis LM, (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23: 1011-1027.